Iressa for EGFR Mutation Negative Non-small Cell Lung Cancer (NSCLC)

Summary

The investigators will examine efficacy and toxicity of gefitinib in Korean patients with EGFR wild tumors diagnosed with direct sequence test.

Timeline

Start

2010-09

Primary completion

2012-08

Completion

—

Drugs

Indications